Enter Values
EBITDA Normalization Formula
Normalized EBITDA = Reported + Add-backs - Gains
Add-backs = Transaction + SBC + Restructuring + Other
Adjustment % = Net Adjustments / Reported EBITDA
Adjustment % = Net Adjustments / Reported EBITDA
Model Assumptions
- All adjustments must be embedded in reported EBITDA starting point
- Standalone normalization only (no synergies or pro forma)
- All adjustments are pre-tax and same period basis
- SBC convention varies by buyer; disclose treatment
- Recurring "one-time" items should not be added back
- Thresholds (10%, 25%) are educational heuristics, not market rules
Normalized EBITDA Results
Normalized EBITDA
$98.0M
Total Add-backs
$18.0M
Net Adjustments
$18.0M
Adjustment %
22.5%
Adjustment percentage of 22.5% is material. Buyers will likely scrutinize individual add-backs, especially SBC and other adjustments.
EBITDA Bridge
Adjustment Breakdown
| Item | Amount ($M) | % of Reported |
|---|---|---|
| Reported EBITDA | $80.0 | - |
| Transaction & Legal | $5.0 | 6.3% |
| Stock-Based Compensation | $8.0 | 10.0% |
| Restructuring | $3.0 | 3.8% |
| Other Adjustments | $2.0 | 2.5% |
| Non-Recurring Gains | $0.0 | 0.0% |
| Normalized EBITDA | $98.0 | 122.5% |
Frequently Asked Questions
Normalized EBITDA is adjusted EBITDA that removes non-recurring items to show the company's sustainable earnings power. It adds back one-time expenses (like restructuring or litigation costs) and subtracts one-time gains (like asset sale proceeds) to provide buyers and sellers with a cleaner baseline for valuation.
SBC is a non-cash expense that doesn't directly affect cash flow. Many M&A buyers add it back when calculating normalized EBITDA. However, convention varies - some buyers argue SBC represents real economic cost to shareholders through dilution. The treatment should always be disclosed, and buyers may apply different conventions based on their valuation approach.
There is no universal cutoff. As educational screening thresholds: adjustments below 10% usually draw less scrutiny; 10-25% represents material adjustments warranting closer review; above 25% may be viewed as aggressive, prompting buyers to question whether management is inflating EBITDA. These are heuristics, not market rules.
"Other Adjustments" draw the most skepticism because they're often vaguely defined. Buyers generally accept well-documented, truly one-time items like litigation settlements or natural disaster costs. Items that appear every year ("recurring non-recurring") will be challenged or excluded.
All else equal, normalized EBITDA directly impacts enterprise value through the EV/EBITDA multiple. If a company trades at 10x EBITDA and normalized EBITDA is $98M instead of reported $80M, implied enterprise value increases from $800M to $980M - a $180M difference. This is why buyers and sellers negotiate add-backs heavily.
One-time gains inflate reported EBITDA above sustainable levels. If a company sold a building for a $10M gain that was embedded in reported EBITDA, that gain won't recur. Subtracting it gives buyers a more accurate picture of ongoing earnings power. Common gains to subtract include asset sale proceeds, insurance settlements, and lawsuit awards - but only if they're already included in your reported EBITDA starting point.
Disclaimer
This calculator is for educational purposes only and provides a simplified EBITDA normalization framework. Actual M&A transactions involve detailed due diligence, negotiated quality of earnings reports, and buyer-specific treatment of add-backs. SBC treatment, restructuring add-backs, and other adjustments are subject to negotiation. This tool should not be used for transaction decisions without professional guidance. Not financial advice.
